SlideShare a Scribd company logo
Impact of Diabetes On
Covid-19
DR. PRABHJOT SAINI BSN MSN PhD(Nursing)
PROFESSOR & PRINCIPAL
SKSS COLLEGE OF NURSING
SARABHA, LUDHIANA, PUNJAB
email: psaini.dr@gmail.com , skssconsarabha@gmail.com
Lots of questions ponder our minds:
 Who contacts covid infection?
 Who is at higher risk?
 What makes diabetics and elderly more at risk?
 What should be done to prevent infection in diabetic population?
 What is the mortality rate among diabetics suffering from covid-
19
 How can we manage the complications?
Unit objectives
 Introduction
 Covid 19 : current scenario
 Epidemiology
 Covid & Diabetes
 Pathogenesis of covid among diabetes
 Control of diabetes
 Management among diabetes during covid infection
Covid-19 : Background
Covid-19
The novel coronavirus
 First identified in Wuhan, China in Dec’ 2019
 It is an enveloped RNA virus
 Also called severe respiratory syndrome coronavirus
(SARS-CoV-2)
 SARS-CoV, MERS-CoV and SARS-CoV-2 can cause
severe disease, whereas HKU1, NL63, OC43 and 229E
are associated with mild symptoms
 SARS-CoV-2 causes the disease COVID-19 Corona
Virus Disease- 2019 (COVID-19)
Covid-19: An overview
 COVID-19 (Coronavirus Disease-2019) is caused by the coronavirus
SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), which
has spread quickly to more than 160 countries across the world.1
 The spreading mechanism of the virus is primarily by transmission of
respiratory droplets between people.1
 The incubation time is on average 6–8 days, followed by 1–2 weeks of
symptomatic disease.
Covid-19: Current Scenario (21st Dec’2020)
Covid-19 : Background
Presenting symptoms
What we know about COVID-19?
 Spreads faster and more efficiently than cold and flu viruses
 A person with COVID might infect up to 2-4 people compared with
1-2 for other viruses
 85-90% will “easily” recover within 2 weeks
 Worldwide, severe disease in people over 60, greater in men,
diabetes and other chronic health conditions
What we don’t know about Covid-19?
How long it has been here?
How many of us has been exposed
or already immune?
Seasonality
Will it “burn out” with
warm weather?
Smoking
How it affect risk?
India difference
Why do risk factors
and strain so different
than other countries
We always read everywhere…..
Are people with diabetes at risk for COVID-19?
 The COVID-19 infection is a double challenge for people with diabetes.
 Diabetes has been reported to be a risk factor for the severity of the
disease
 Much attention has been focused on people with diabetes because of poor
prognosis in those with the infection.
 Initial reports were mainly on people with type 2 diabetes, although
recent surveys have shown that individuals with type 1 diabetes are also
at risk of severe COVID-19.
 The reason for worse prognosis in diabetes- multifactorial (syndromic
nature of diabetes).
Are people with diabetes at risk for COVID-19?
 Age, sex, ethnicity, comorbidities such as hypertension and
cardiovascular disease, obesity, and a pro-inflammatory and pro-
coagulative state all contribute to the risk of worse outcomes.
 Glucose-lowering agents and anti-viral treatments can modulate the risk
Diabetes & Covid-19
Myth: People with diabetes will die with
covid-19 infection
Reality: People can have diabetes and get
well
But how?
If I am a diabetic patient....
I may get infection just
like any other…
but if I get it....
I may have more
severe complications
Current CDC : Definition of High risk
 Those at high risk for severe illness from COVID-19 include:
 People aged >65 years
 People living in nursing home or long-term care facility
 Other high risk conditions could include:
 People with chronic lung disease or moderate/severe asthma
 People who have heart diseases with complications
 People who are immunocompromized
 People of any age with a BMI>40 or underlined medical condition, particularly if not well controlled, such
as those with diabetes, renal failure or liver disease might also be at high risk.
 People who are pregnant should be monitored since they are known to be at risk with severe viral illness
(lack of evidence)
Susceptibility to get infected?
Pathogenesis of diabetes & covid
infection
Pathogenesis:
Diabetes with covid infection
I. AMPLIFICATION
 On beta cell of langerhans in pancreas: ACE 2 receptors increase expression due to
hyperglycemia
 Increases attachment of coronavirus: causing more infection
 Increase viral load in beta cells causing its destruction
II. VASCULAR PERFUSION
 Hyperglycemia (increased glucose will attach to proteins) and stick on Endothelial cells
of artery (known as non-enzymatic glycosylation) –normally shouldn’t attach
 Glycation moves down to basement membrane and cause atherosclerosis in arteries
 Plaque is formed, blood vessels become narrow and thicken
 Cause reduced blood supply to organs like kidneys, tissues, liver, lungs, etc thus
reducing supply of immune cells at target organ of infection.
Pathogenesis:
Diabetes with covid infection
III. INSULIN RESISTANCE
Diabetes mellitus causes decreased glucose inside cells: causing lack of energy
 Resulting in adipocytes releasing free fatty acids
 FFA get into cells, causing insulin resistance further leading to reduced
glucose uptake
 Causing reactive oxygen species (ROS)
 Leading to damage of cells – damage increases multiple folds in covid-19
infection
Pathogenesis:
Diabetes with covid infection
IV. IMMUNE DYSREGULATION
 Type of response that we get in the immune system- immune dysregulation (suppressed
response)
1. Acidic enviornment – less CHO causing acid production, ketones produced, cellular
enzymes not function properly. Immune cells cannot function correctly
2. Immune system is not coordinated: In presence of COVID -Macrophages, neutrophil
cells and CD4 cells are weakened and increased of IL-17 causes pro-inflammatory cells
(promote unnecessary inflammatory response causing damage
3. Binding to endothelium by non enzymatic glycation
Pathogenesis
During COVID infection in lungs in diabetic patients
 The immune system will not work properly
 Leading to chemotaxis, diapedesis of Blood vessels happen and inflammatory cells
are not able to reach in appropriate amount to area of infection
 In hyperglycemia
 Calcium influx occurs in cells- causing cells (poly-morphonuclear cells) function to
reduce
 Lower ATP in cells- no energy in immune cells (macrophages) to destroy the corona
cells
 More fatty acids causing –insulin resistance
 Beta defensive function is reduced in viral infection by covid. Causing immune cell
function goes down
 Macrophage becomes suppressed in diabetes causing T helper 17 cells becomes
active-pro-inflammatory cells become active causing cytokine storm leading to
dysregulation (vit D consumption reduced pro-inflammatory effect)
What action needs to be taken?
Careful monitoring blood glucose levels
Time-in-Range : Blood glucose regulation
Time-in-Range” (TIR) is the percentage of time that a person spends
with their blood glucose levels in a target range.
The range will vary depending on the person, but general guidelines
suggest starting with a range of 70 to 180 mg/dl.
Investigating regular blood sugar levels
Ketone testing
Management of diabetes with
covid-19 Infection
Diabetes & Covid-19: Management
 Stay calm
 Know what to do
I. Preparation
II. Prevention
III. Know emergency sypmtoms
IV. Be watchful of ketoacidosis
Preparedness
 Preparation
 Purchance additional non-perishable food and supplies,
 Extra medication
 Glucometer & test strips
 Glucagon
 Ketone & test strips
 Sugary & non-sugary fluids
 Simple carbohydrates for treating hypoglycemia
 Electrolyte tablets
Prevention
 Stop the spread of infection
 Wash hands frequently and thoroughly
 Disinfect “high touch” surfaces & objects in home regularly
 Cover mouth during cough & sneezes with tissue, and wash
hands
 Keep a distance of atleast six feet with others
 Stay home as much as possible
 Closely monitor blood glucose levels (keep in time range)
 Continue taking insulin or diabetes medication
 Stay hydrated with fluids
Seek medical attention
 Difficulty breathing
 Persistant pain or pressure in the chest
 Confusion/ inability to stay alert
 Bluish lips or face
Management of Type 1 DM
Management of Type 2 DM
Dietary management
Dietary management
Exercise in DIABETES ! A FEW
ALERTS!!
 Keep exercising as per routine: keep social
distancing at all times
 Do Not Exercise :
 In full or empty stomach
 When insulin action is at peak
 Under extremes of temperature
 During other illnesses
 If blood sugar is over 250 and ketones present
 Is chest pain occurs during exercise
“Sick Day”
 Avoid dehydration : when vomiting, diarrhea, fever, extreme
temperatures
 Drink plenty of fluids
 Prevent hypoglycemia
 Maintain and check blood glucose, BP
 Do not stop any medication till advised
When to test for ketones?
 If blood sugar is high (>16mmol)
 Check urine or blood ketones every 4hours
 If taking SGLT2 inhibitors , get test of ketones if hyperglycemia
 More insulin may be administrered to correct hyperglycemia
Self-education/management of diabetes in
COVID-19 pandemic
 PWD follow their “current routine” including
 checking feet daily,
 keeping to a healthy diet,
 and keeping active.
 The interventions generally fall into four categories:
 text-message;
 mobile phone app;
 web or computer-based;
 self-monitoring of blood glucose.
Summary
 Diabetes patients have impaired immune-response to infection.
 No risk of getting it, however there could be increased risk of complications after
getting positive
 Poor glycaemic control impairs several aspects of the immune response to viral
infection and also to the potential secondary infection in the lungs.
 Poor glycaemic control is a risk factor for covid-19 infection and adverse outcomes.
 However, the reverse is also true and the risk of infection, including covid-19, can be
reduced through good glycaemic control.
 Covid and diabetes can cause loss of glycaemic control, and treatment of
hyperglycaemia is difficult during intercurrent disease
 To maintain optimal glycaemic control requires more frequent blood glucose
monitoring
 In many patients with type 2 diabetes, insulin treatment will be preferred and need
to be initiated.
 In patients with type 1 diabetes, the insulin doses should be titrated using
frequent glucose and ketone monitoring to avoid hypoglycaemia in patients
 Diabetes patients to treat for COVID-19, may need increased
requirement of hospitalisation.
 Patients with diabetes need intensive attention to reduce the risk of
fatalities.
 Patients with diabetes should follow the general prevention advice
given by the authorities thoroughly to avoid infection with COVID-19.
References
 Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020; doi: 10.1001/jama.2020.3072.
 Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered,
retrospective, observational study. Lancet Respir Med. 2020; doi: 10.1016/S2213-2600(20)30079-5.
 Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; doi: 10.1056/NEJMoa2002032.
 Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; doi: 10.1111/all.14238.
 Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int
J Infect Dis. 2020; pii: S1201-9712(20)30136-3. doi: 10.1016/j.ijid.2020.03.017.
 Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive
Care Med. 2020; doi: 10.1007/s00134-020-05991-x.
 Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet.
2020; pii: S0140-6736(20)30566-3. doi: 10.1016/S0140-6736(20)30566-3.
 Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia
in Wuhan, China. JAMA Intern Med. 2020; doi: 10.1001/jamainternmed.2020.0994.
 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of
72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; doi: 10.1001/jama.2020.2648.
 Leung C. Clinical features of deaths in the novel coronavirus epidemic in China. Rev Med Virol. 2020;e2103. doi: 10.1002/rmv.2103.
 Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; doi: 10.1007/s00392-020-01626-9.
 Yang JK, Feng Y, Yuan MY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23:623–8.
 Schoen K, Horvat N, Guerreiro NFC, et al. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis.
2019;19:964.
 Wang W, Chen H, Li Q, et al. Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia. BMC Infect Dis. 2011;11:104.
 Ferlita S, Yegiazaryan A, Noori N et al. Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially mycobacterium tuberculosis. J Clin Med.
2019;8. pii: E2219.
 Critchley JA, Carey IM, Harris T et al. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes
Care. 2018;41:2127–35.
 Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes (Lond). 2013;37:333–40.
 Honce R, Schultz-Cherry S. Impact of obesity on influenza a virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10:1071.
 Almond MH, Edwards MR, Barclay WS, Johnston SL. Obesity and susceptibility to severe outcomes following respiratory viral infection. Thorax. 2013;68:684–6.
 Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12:755–67.
 Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J Virol.
2020;94. pii: e00127-20.
 Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; pii:
S0092-8674(20)30229-4. doi: 10.1016/j.cell.2020.02.052.
 Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney
diseases. Pharmacol Res. 2017;125:21–38.
Thank you

More Related Content

What's hot

Nutrition and cancer
Nutrition and cancerNutrition and cancer
Stress management with nutrition and herbs (1)
Stress management with nutrition and herbs (1)Stress management with nutrition and herbs (1)
Stress management with nutrition and herbs (1)
Dr Taruna Yadav
 
Chronic obstructive pulmonary disorder (copd)
Chronic obstructive pulmonary disorder (copd)Chronic obstructive pulmonary disorder (copd)
Chronic obstructive pulmonary disorder (copd)
Jamilah AlQahtani
 
Upper respiratory tract infection & otitis media
Upper respiratory tract infection & otitis mediaUpper respiratory tract infection & otitis media
Upper respiratory tract infection & otitis media
Lulwah Althumali
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
shabna lekha
 
Emerging and Re-emerging Infectious Diseases
Emerging and Re-emerging Infectious DiseasesEmerging and Re-emerging Infectious Diseases
Emerging and Re-emerging Infectious Diseases
Farooq Khan
 
Evaluation and management of a patient with cough
Evaluation and management of a patient with coughEvaluation and management of a patient with cough
Evaluation and management of a patient with cough
MosesMwavali
 
Influenza
InfluenzaInfluenza
Influenza
Mohan Bastola
 
Bronchitis afpa rdmc_06_dr meghanaben mehta_20180422
Bronchitis afpa rdmc_06_dr meghanaben mehta_20180422Bronchitis afpa rdmc_06_dr meghanaben mehta_20180422
Bronchitis afpa rdmc_06_dr meghanaben mehta_20180422
Parthiv Mehta
 
Obesity
ObesityObesity
Obesity
uog
 
Acute severe asthma
Acute severe asthmaAcute severe asthma
Acute severe asthma
Mohamed Albesh
 
Post covid sequle
Post covid sequlePost covid sequle
Post covid sequle
TarekHamdy17
 
7 Upper respiratory tract infections
7 Upper respiratory tract infections7 Upper respiratory tract infections
7 Upper respiratory tract infections
Yaser Ammar
 
Hepatitis c
Hepatitis c Hepatitis c
Hepatitis c
Dr. Armaan Singh
 
Copd 2
Copd 2Copd 2
Respiratory Complications of COVID-19
Respiratory Complications of COVID-19Respiratory Complications of COVID-19
Respiratory Complications of COVID-19
riyadhbeximco
 
Covid 19
Covid 19Covid 19
Covid 19
RUHIPREETKAUR
 
Reducing saturated fat intake for cardiovascular disease: What's the evidence?
Reducing saturated fat intake for cardiovascular disease: What's the evidence? Reducing saturated fat intake for cardiovascular disease: What's the evidence?
Reducing saturated fat intake for cardiovascular disease: What's the evidence?
Health Evidence™
 

What's hot (20)

Nutrition and cancer
Nutrition and cancerNutrition and cancer
Nutrition and cancer
 
Stress management with nutrition and herbs (1)
Stress management with nutrition and herbs (1)Stress management with nutrition and herbs (1)
Stress management with nutrition and herbs (1)
 
Chronic obstructive pulmonary disorder (copd)
Chronic obstructive pulmonary disorder (copd)Chronic obstructive pulmonary disorder (copd)
Chronic obstructive pulmonary disorder (copd)
 
Upper respiratory tract infection & otitis media
Upper respiratory tract infection & otitis mediaUpper respiratory tract infection & otitis media
Upper respiratory tract infection & otitis media
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
 
Emerging and Re-emerging Infectious Diseases
Emerging and Re-emerging Infectious DiseasesEmerging and Re-emerging Infectious Diseases
Emerging and Re-emerging Infectious Diseases
 
Evaluation and management of a patient with cough
Evaluation and management of a patient with coughEvaluation and management of a patient with cough
Evaluation and management of a patient with cough
 
Life course epidemiology
Life course epidemiologyLife course epidemiology
Life course epidemiology
 
Nutrition and Asthma
Nutrition and Asthma Nutrition and Asthma
Nutrition and Asthma
 
Influenza
InfluenzaInfluenza
Influenza
 
Bronchitis afpa rdmc_06_dr meghanaben mehta_20180422
Bronchitis afpa rdmc_06_dr meghanaben mehta_20180422Bronchitis afpa rdmc_06_dr meghanaben mehta_20180422
Bronchitis afpa rdmc_06_dr meghanaben mehta_20180422
 
Obesity
ObesityObesity
Obesity
 
Acute severe asthma
Acute severe asthmaAcute severe asthma
Acute severe asthma
 
Post covid sequle
Post covid sequlePost covid sequle
Post covid sequle
 
7 Upper respiratory tract infections
7 Upper respiratory tract infections7 Upper respiratory tract infections
7 Upper respiratory tract infections
 
Hepatitis c
Hepatitis c Hepatitis c
Hepatitis c
 
Copd 2
Copd 2Copd 2
Copd 2
 
Respiratory Complications of COVID-19
Respiratory Complications of COVID-19Respiratory Complications of COVID-19
Respiratory Complications of COVID-19
 
Covid 19
Covid 19Covid 19
Covid 19
 
Reducing saturated fat intake for cardiovascular disease: What's the evidence?
Reducing saturated fat intake for cardiovascular disease: What's the evidence? Reducing saturated fat intake for cardiovascular disease: What's the evidence?
Reducing saturated fat intake for cardiovascular disease: What's the evidence?
 

Similar to Impact of diabetes on covid-19

1589983617041_Diabetes Mellitus by Sanjana (1).pptx
1589983617041_Diabetes Mellitus by Sanjana (1).pptx1589983617041_Diabetes Mellitus by Sanjana (1).pptx
1589983617041_Diabetes Mellitus by Sanjana (1).pptx
geetha32
 
Nursing Care of Family with School age Disorders.pptx
Nursing Care of Family with School age Disorders.pptxNursing Care of Family with School age Disorders.pptx
Nursing Care of Family with School age Disorders.pptx
Maynard Gabriel
 
8 Major Risk Factors for Covid-19 Infection
8 Major Risk Factors for Covid-19 Infection8 Major Risk Factors for Covid-19 Infection
8 Major Risk Factors for Covid-19 Infection
Dr Satish Pandav
 
Student Work - Diabetes
Student Work - DiabetesStudent Work - Diabetes
Student Work - Diabetesjeremyschriner
 
Diabetes mellitus - britannica online encyclopedia
Diabetes mellitus  - britannica online encyclopediaDiabetes mellitus  - britannica online encyclopedia
Diabetes mellitus - britannica online encyclopedia
Rohinikumar T
 
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptxEPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
DrHarimuBargayary
 
All About Diabetes.pdf
All About Diabetes.pdfAll About Diabetes.pdf
All About Diabetes.pdf
RobinaYasmin7
 
How To Control Obesity?
How To Control Obesity? How To Control Obesity?
How To Control Obesity?
Karnim
 
All about diabetes symptoms causes types
All about diabetes symptoms causes typesAll about diabetes symptoms causes types
All about diabetes symptoms causes types
HimanshuKumar206305
 
Complications of diabetes-paediatric and adolescent.pptx
Complications of diabetes-paediatric and adolescent.pptxComplications of diabetes-paediatric and adolescent.pptx
Complications of diabetes-paediatric and adolescent.pptx
Jamakala Obaiah
 
Risk factors for diabetes during childhood
Risk factors for diabetes during childhoodRisk factors for diabetes during childhood
Risk factors for diabetes during childhood
Pratyush1693
 
Covid 19 basic
Covid 19 basicCovid 19 basic
Covid 19 basic
MuhammadBilal238486
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Md Jahirul Islam Sojib
 
Diabetes and TB The deadly Combo.pptx
Diabetes and TB The deadly Combo.pptxDiabetes and TB The deadly Combo.pptx
Diabetes and TB The deadly Combo.pptx
Dr. Divyagunjan Sahu (PT)
 
COMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUS
COMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUSCOMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUS
COMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUS
Anas Indabawa
 
NEW NCD GUIDELINE.pptx
NEW NCD  GUIDELINE.pptxNEW NCD  GUIDELINE.pptx
NEW NCD GUIDELINE.pptx
ImanuIliyas
 
Diabetes
DiabetesDiabetes
Diabetes mellitus
Diabetes  mellitusDiabetes  mellitus
Diabetes mellitus
SushantLuitel1
 
Protecting your Future from Diabetes-Crimson Publishers
Protecting your Future from Diabetes-Crimson Publishers Protecting your Future from Diabetes-Crimson Publishers
Protecting your Future from Diabetes-Crimson Publishers
CrimsonPublishersIOD
 

Similar to Impact of diabetes on covid-19 (20)

1589983617041_Diabetes Mellitus by Sanjana (1).pptx
1589983617041_Diabetes Mellitus by Sanjana (1).pptx1589983617041_Diabetes Mellitus by Sanjana (1).pptx
1589983617041_Diabetes Mellitus by Sanjana (1).pptx
 
Nursing Care of Family with School age Disorders.pptx
Nursing Care of Family with School age Disorders.pptxNursing Care of Family with School age Disorders.pptx
Nursing Care of Family with School age Disorders.pptx
 
8 Major Risk Factors for Covid-19 Infection
8 Major Risk Factors for Covid-19 Infection8 Major Risk Factors for Covid-19 Infection
8 Major Risk Factors for Covid-19 Infection
 
Student Work - Diabetes
Student Work - DiabetesStudent Work - Diabetes
Student Work - Diabetes
 
Diabetes mellitus - britannica online encyclopedia
Diabetes mellitus  - britannica online encyclopediaDiabetes mellitus  - britannica online encyclopedia
Diabetes mellitus - britannica online encyclopedia
 
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptxEPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
 
All About Diabetes.pdf
All About Diabetes.pdfAll About Diabetes.pdf
All About Diabetes.pdf
 
How To Control Obesity?
How To Control Obesity? How To Control Obesity?
How To Control Obesity?
 
All about diabetes symptoms causes types
All about diabetes symptoms causes typesAll about diabetes symptoms causes types
All about diabetes symptoms causes types
 
Complications of diabetes-paediatric and adolescent.pptx
Complications of diabetes-paediatric and adolescent.pptxComplications of diabetes-paediatric and adolescent.pptx
Complications of diabetes-paediatric and adolescent.pptx
 
Risk factors for diabetes during childhood
Risk factors for diabetes during childhoodRisk factors for diabetes during childhood
Risk factors for diabetes during childhood
 
Covid 19 basic
Covid 19 basicCovid 19 basic
Covid 19 basic
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetes and TB The deadly Combo.pptx
Diabetes and TB The deadly Combo.pptxDiabetes and TB The deadly Combo.pptx
Diabetes and TB The deadly Combo.pptx
 
COMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUS
COMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUSCOMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUS
COMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUS
 
NEW NCD GUIDELINE.pptx
NEW NCD  GUIDELINE.pptxNEW NCD  GUIDELINE.pptx
NEW NCD GUIDELINE.pptx
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes mellitus
Diabetes  mellitusDiabetes  mellitus
Diabetes mellitus
 
Protecting your Future from Diabetes-Crimson Publishers
Protecting your Future from Diabetes-Crimson Publishers Protecting your Future from Diabetes-Crimson Publishers
Protecting your Future from Diabetes-Crimson Publishers
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 

More from Prabhjot Saini

Prabhjot Saini.pptx
Prabhjot Saini.pptxPrabhjot Saini.pptx
Prabhjot Saini.pptx
Prabhjot Saini
 
Penile size: How much does it matter?
Penile size: How much does it matter?Penile size: How much does it matter?
Penile size: How much does it matter?
Prabhjot Saini
 
Constipation in hospitalized patients
Constipation in hospitalized patientsConstipation in hospitalized patients
Constipation in hospitalized patients
Prabhjot Saini
 
Hypertension in older population
Hypertension in older populationHypertension in older population
Hypertension in older population
Prabhjot Saini
 
Hypertension and Stroke in older people
Hypertension and Stroke in older peopleHypertension and Stroke in older people
Hypertension and Stroke in older people
Prabhjot Saini
 
Communication with ICU patients: Knowing their needs
Communication with ICU patients: Knowing their needsCommunication with ICU patients: Knowing their needs
Communication with ICU patients: Knowing their needs
Prabhjot Saini
 
Lifestyle modifications in Diabetes mellitus
Lifestyle modifications in Diabetes mellitusLifestyle modifications in Diabetes mellitus
Lifestyle modifications in Diabetes mellitus
Prabhjot Saini
 
Care of brain dead
Care of brain deadCare of brain dead
Care of brain dead
Prabhjot Saini
 
Men die more than women
Men die more than women Men die more than women
Men die more than women
Prabhjot Saini
 
Evidence Based Nursing Practice: Current Scenario & eay forward
Evidence Based Nursing Practice: Current Scenario & eay forwardEvidence Based Nursing Practice: Current Scenario & eay forward
Evidence Based Nursing Practice: Current Scenario & eay forward
Prabhjot Saini
 

More from Prabhjot Saini (10)

Prabhjot Saini.pptx
Prabhjot Saini.pptxPrabhjot Saini.pptx
Prabhjot Saini.pptx
 
Penile size: How much does it matter?
Penile size: How much does it matter?Penile size: How much does it matter?
Penile size: How much does it matter?
 
Constipation in hospitalized patients
Constipation in hospitalized patientsConstipation in hospitalized patients
Constipation in hospitalized patients
 
Hypertension in older population
Hypertension in older populationHypertension in older population
Hypertension in older population
 
Hypertension and Stroke in older people
Hypertension and Stroke in older peopleHypertension and Stroke in older people
Hypertension and Stroke in older people
 
Communication with ICU patients: Knowing their needs
Communication with ICU patients: Knowing their needsCommunication with ICU patients: Knowing their needs
Communication with ICU patients: Knowing their needs
 
Lifestyle modifications in Diabetes mellitus
Lifestyle modifications in Diabetes mellitusLifestyle modifications in Diabetes mellitus
Lifestyle modifications in Diabetes mellitus
 
Care of brain dead
Care of brain deadCare of brain dead
Care of brain dead
 
Men die more than women
Men die more than women Men die more than women
Men die more than women
 
Evidence Based Nursing Practice: Current Scenario & eay forward
Evidence Based Nursing Practice: Current Scenario & eay forwardEvidence Based Nursing Practice: Current Scenario & eay forward
Evidence Based Nursing Practice: Current Scenario & eay forward
 

Recently uploaded

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 

Recently uploaded (20)

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 

Impact of diabetes on covid-19

  • 1. Impact of Diabetes On Covid-19 DR. PRABHJOT SAINI BSN MSN PhD(Nursing) PROFESSOR & PRINCIPAL SKSS COLLEGE OF NURSING SARABHA, LUDHIANA, PUNJAB email: psaini.dr@gmail.com , skssconsarabha@gmail.com
  • 2. Lots of questions ponder our minds:  Who contacts covid infection?  Who is at higher risk?  What makes diabetics and elderly more at risk?  What should be done to prevent infection in diabetic population?  What is the mortality rate among diabetics suffering from covid- 19  How can we manage the complications?
  • 3. Unit objectives  Introduction  Covid 19 : current scenario  Epidemiology  Covid & Diabetes  Pathogenesis of covid among diabetes  Control of diabetes  Management among diabetes during covid infection
  • 5. Covid-19 The novel coronavirus  First identified in Wuhan, China in Dec’ 2019  It is an enveloped RNA virus  Also called severe respiratory syndrome coronavirus (SARS-CoV-2)  SARS-CoV, MERS-CoV and SARS-CoV-2 can cause severe disease, whereas HKU1, NL63, OC43 and 229E are associated with mild symptoms  SARS-CoV-2 causes the disease COVID-19 Corona Virus Disease- 2019 (COVID-19)
  • 6. Covid-19: An overview  COVID-19 (Coronavirus Disease-2019) is caused by the coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), which has spread quickly to more than 160 countries across the world.1  The spreading mechanism of the virus is primarily by transmission of respiratory droplets between people.1  The incubation time is on average 6–8 days, followed by 1–2 weeks of symptomatic disease.
  • 7. Covid-19: Current Scenario (21st Dec’2020)
  • 10. What we know about COVID-19?  Spreads faster and more efficiently than cold and flu viruses  A person with COVID might infect up to 2-4 people compared with 1-2 for other viruses  85-90% will “easily” recover within 2 weeks  Worldwide, severe disease in people over 60, greater in men, diabetes and other chronic health conditions
  • 11. What we don’t know about Covid-19? How long it has been here? How many of us has been exposed or already immune? Seasonality Will it “burn out” with warm weather? Smoking How it affect risk? India difference Why do risk factors and strain so different than other countries
  • 12. We always read everywhere…..
  • 13.
  • 14. Are people with diabetes at risk for COVID-19?  The COVID-19 infection is a double challenge for people with diabetes.  Diabetes has been reported to be a risk factor for the severity of the disease  Much attention has been focused on people with diabetes because of poor prognosis in those with the infection.  Initial reports were mainly on people with type 2 diabetes, although recent surveys have shown that individuals with type 1 diabetes are also at risk of severe COVID-19.  The reason for worse prognosis in diabetes- multifactorial (syndromic nature of diabetes).
  • 15. Are people with diabetes at risk for COVID-19?  Age, sex, ethnicity, comorbidities such as hypertension and cardiovascular disease, obesity, and a pro-inflammatory and pro- coagulative state all contribute to the risk of worse outcomes.  Glucose-lowering agents and anti-viral treatments can modulate the risk
  • 17. Myth: People with diabetes will die with covid-19 infection Reality: People can have diabetes and get well
  • 19. If I am a diabetic patient.... I may get infection just like any other… but if I get it.... I may have more severe complications
  • 20. Current CDC : Definition of High risk  Those at high risk for severe illness from COVID-19 include:  People aged >65 years  People living in nursing home or long-term care facility  Other high risk conditions could include:  People with chronic lung disease or moderate/severe asthma  People who have heart diseases with complications  People who are immunocompromized  People of any age with a BMI>40 or underlined medical condition, particularly if not well controlled, such as those with diabetes, renal failure or liver disease might also be at high risk.  People who are pregnant should be monitored since they are known to be at risk with severe viral illness (lack of evidence)
  • 21.
  • 22.
  • 23.
  • 25.
  • 26.
  • 27.
  • 28. Pathogenesis of diabetes & covid infection
  • 29. Pathogenesis: Diabetes with covid infection I. AMPLIFICATION  On beta cell of langerhans in pancreas: ACE 2 receptors increase expression due to hyperglycemia  Increases attachment of coronavirus: causing more infection  Increase viral load in beta cells causing its destruction II. VASCULAR PERFUSION  Hyperglycemia (increased glucose will attach to proteins) and stick on Endothelial cells of artery (known as non-enzymatic glycosylation) –normally shouldn’t attach  Glycation moves down to basement membrane and cause atherosclerosis in arteries  Plaque is formed, blood vessels become narrow and thicken  Cause reduced blood supply to organs like kidneys, tissues, liver, lungs, etc thus reducing supply of immune cells at target organ of infection.
  • 30. Pathogenesis: Diabetes with covid infection III. INSULIN RESISTANCE Diabetes mellitus causes decreased glucose inside cells: causing lack of energy  Resulting in adipocytes releasing free fatty acids  FFA get into cells, causing insulin resistance further leading to reduced glucose uptake  Causing reactive oxygen species (ROS)  Leading to damage of cells – damage increases multiple folds in covid-19 infection
  • 31. Pathogenesis: Diabetes with covid infection IV. IMMUNE DYSREGULATION  Type of response that we get in the immune system- immune dysregulation (suppressed response) 1. Acidic enviornment – less CHO causing acid production, ketones produced, cellular enzymes not function properly. Immune cells cannot function correctly 2. Immune system is not coordinated: In presence of COVID -Macrophages, neutrophil cells and CD4 cells are weakened and increased of IL-17 causes pro-inflammatory cells (promote unnecessary inflammatory response causing damage 3. Binding to endothelium by non enzymatic glycation
  • 32. Pathogenesis During COVID infection in lungs in diabetic patients  The immune system will not work properly  Leading to chemotaxis, diapedesis of Blood vessels happen and inflammatory cells are not able to reach in appropriate amount to area of infection  In hyperglycemia  Calcium influx occurs in cells- causing cells (poly-morphonuclear cells) function to reduce  Lower ATP in cells- no energy in immune cells (macrophages) to destroy the corona cells  More fatty acids causing –insulin resistance  Beta defensive function is reduced in viral infection by covid. Causing immune cell function goes down  Macrophage becomes suppressed in diabetes causing T helper 17 cells becomes active-pro-inflammatory cells become active causing cytokine storm leading to dysregulation (vit D consumption reduced pro-inflammatory effect)
  • 33. What action needs to be taken?
  • 34. Careful monitoring blood glucose levels
  • 35.
  • 36. Time-in-Range : Blood glucose regulation Time-in-Range” (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range. The range will vary depending on the person, but general guidelines suggest starting with a range of 70 to 180 mg/dl.
  • 37.
  • 39.
  • 40.
  • 41.
  • 43. Management of diabetes with covid-19 Infection
  • 44.
  • 45. Diabetes & Covid-19: Management  Stay calm  Know what to do I. Preparation II. Prevention III. Know emergency sypmtoms IV. Be watchful of ketoacidosis
  • 46. Preparedness  Preparation  Purchance additional non-perishable food and supplies,  Extra medication  Glucometer & test strips  Glucagon  Ketone & test strips  Sugary & non-sugary fluids  Simple carbohydrates for treating hypoglycemia  Electrolyte tablets
  • 47. Prevention  Stop the spread of infection  Wash hands frequently and thoroughly  Disinfect “high touch” surfaces & objects in home regularly  Cover mouth during cough & sneezes with tissue, and wash hands  Keep a distance of atleast six feet with others  Stay home as much as possible  Closely monitor blood glucose levels (keep in time range)  Continue taking insulin or diabetes medication  Stay hydrated with fluids
  • 48. Seek medical attention  Difficulty breathing  Persistant pain or pressure in the chest  Confusion/ inability to stay alert  Bluish lips or face
  • 53.
  • 54.
  • 55.
  • 56. Exercise in DIABETES ! A FEW ALERTS!!  Keep exercising as per routine: keep social distancing at all times  Do Not Exercise :  In full or empty stomach  When insulin action is at peak  Under extremes of temperature  During other illnesses  If blood sugar is over 250 and ketones present  Is chest pain occurs during exercise
  • 57.
  • 58. “Sick Day”  Avoid dehydration : when vomiting, diarrhea, fever, extreme temperatures  Drink plenty of fluids  Prevent hypoglycemia  Maintain and check blood glucose, BP  Do not stop any medication till advised
  • 59.
  • 60. When to test for ketones?  If blood sugar is high (>16mmol)  Check urine or blood ketones every 4hours  If taking SGLT2 inhibitors , get test of ketones if hyperglycemia  More insulin may be administrered to correct hyperglycemia
  • 61. Self-education/management of diabetes in COVID-19 pandemic  PWD follow their “current routine” including  checking feet daily,  keeping to a healthy diet,  and keeping active.  The interventions generally fall into four categories:  text-message;  mobile phone app;  web or computer-based;  self-monitoring of blood glucose.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69. Summary  Diabetes patients have impaired immune-response to infection.  No risk of getting it, however there could be increased risk of complications after getting positive  Poor glycaemic control impairs several aspects of the immune response to viral infection and also to the potential secondary infection in the lungs.  Poor glycaemic control is a risk factor for covid-19 infection and adverse outcomes.  However, the reverse is also true and the risk of infection, including covid-19, can be reduced through good glycaemic control.
  • 70.  Covid and diabetes can cause loss of glycaemic control, and treatment of hyperglycaemia is difficult during intercurrent disease  To maintain optimal glycaemic control requires more frequent blood glucose monitoring  In many patients with type 2 diabetes, insulin treatment will be preferred and need to be initiated.  In patients with type 1 diabetes, the insulin doses should be titrated using frequent glucose and ketone monitoring to avoid hypoglycaemia in patients
  • 71.  Diabetes patients to treat for COVID-19, may need increased requirement of hospitalisation.  Patients with diabetes need intensive attention to reduce the risk of fatalities.  Patients with diabetes should follow the general prevention advice given by the authorities thoroughly to avoid infection with COVID-19.
  • 72. References  Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020; doi: 10.1001/jama.2020.3072.  Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; doi: 10.1016/S2213-2600(20)30079-5.  Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; doi: 10.1056/NEJMoa2002032.  Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; doi: 10.1111/all.14238.  Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020; pii: S1201-9712(20)30136-3. doi: 10.1016/j.ijid.2020.03.017.  Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; doi: 10.1007/s00134-020-05991-x.  Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; pii: S0140-6736(20)30566-3. doi: 10.1016/S0140-6736(20)30566-3.  Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; doi: 10.1001/jamainternmed.2020.0994.  Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; doi: 10.1001/jama.2020.2648.  Leung C. Clinical features of deaths in the novel coronavirus epidemic in China. Rev Med Virol. 2020;e2103. doi: 10.1002/rmv.2103.
  • 73.  Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; doi: 10.1007/s00392-020-01626-9.  Yang JK, Feng Y, Yuan MY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23:623–8.  Schoen K, Horvat N, Guerreiro NFC, et al. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis. 2019;19:964.  Wang W, Chen H, Li Q, et al. Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia. BMC Infect Dis. 2011;11:104.  Ferlita S, Yegiazaryan A, Noori N et al. Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially mycobacterium tuberculosis. J Clin Med. 2019;8. pii: E2219.  Critchley JA, Carey IM, Harris T et al. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018;41:2127–35.  Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes (Lond). 2013;37:333–40.  Honce R, Schultz-Cherry S. Impact of obesity on influenza a virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10:1071.  Almond MH, Edwards MR, Barclay WS, Johnston SL. Obesity and susceptibility to severe outcomes following respiratory viral infection. Thorax. 2013;68:684–6.  Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12:755–67.  Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94. pii: e00127-20.  Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; pii: S0092-8674(20)30229-4. doi: 10.1016/j.cell.2020.02.052.  Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res. 2017;125:21–38.
  • 74.
  • 75.
  • 76.

Editor's Notes

  1. Coronavirus is for ages … as it causes flu, but this strain of virus is new which could be dangerous for human beings
  2. Doesn’t mean every patient with diabetes will be at risk, and everyone will be fatal
  3. Time-in-Range” (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range. The range will vary depending on the person, but general guidelines suggest starting with a range of 70 to 180 mg/dl.
  4. Time-in-Range” (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range. The range will vary depending on the person, but general guidelines suggest starting with a range of 70 to 180 mg/dl.
  5. Sodium glucose transport protein inhibitor Glucagon like peptides
  6. Never stop insulin even though diet and exercise is ok